IMCLONE LLC logo

IMCLONE LLC

35 Marks
LLC
First Filed:Apr 4, 2000Latest Filed:Jun 20, 2014Address:www.lilly.com, New York, NY 10016

Portfolio Overview

Registered
5(14%)
Dead
30(86%)

Top Classes

Class 5
Pharmaceuticals
32(91%)
Class 42
Software, IT Services & Scientific Research
5(14%)
Class 1
Industrial Chemicals & Adhesives
2(6%)

TTAB Proceedings

No litigation activity

Top Firms

ELI LILLY AND COMPANY(Jun 2014)
25

Trademark Activity Timeline(2000 – 2016)

Trademark Portfolio

35 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
CYRAMZA
CYRAMZA
Service Mark
Combined
REGISTERED
Owner:
Serial:86315717
Filed:Jun 20, 2014
Classes:44
Registration:4899164
Registered:Feb 9, 2016
Goods & Services
Medical information services in the field of cancer
CYRAMZA
CYRAMZA
Trademark
Combined
ABANDONED
Owner:
Serial:86241873
Filed:Apr 3, 2014
Classes:5
CYRAMZE
CYRAMZE
Trademark
Word
ABANDONED
Owner:
Serial:85887825
Filed:Mar 27, 2013
Classes:5
CYRAMZO
CYRAMZO
Trademark
Word
ABANDONED
Owner:
Serial:85887872
Filed:Mar 27, 2013
Classes:5
CYRAMGIO
CYRAMGIO
Trademark
Word
ABANDONED
Owner:
Serial:85822795
Filed:Jan 14, 2013
Classes:5
CYRRAMZ
CYRRAMZ
Trademark
Word
ABANDONED
Owner:
Serial:85822796
Filed:Jan 14, 2013
Classes:5
CYRAMZ
CYRAMZ
Trademark
Word
ABANDONED
Owner:
Serial:85817179
Filed:Jan 7, 2013
Classes:5
CYRAMSA
CYRAMSA
Trademark
Word
ABANDONED
Owner:
Serial:85551163
Filed:Feb 23, 2012
Classes:5
CYRAMZZ
CYRAMZZ
Trademark
Word
ABANDONED
Owner:
Serial:85551165
Filed:Feb 23, 2012
Classes:5
CYRAMZZA
CYRAMZZA
Trademark
Word
ABANDONED
Owner:
Serial:85551169
Filed:Feb 23, 2012
Classes:5
CYRRAMZA
CYRRAMZA
Trademark
Word
ABANDONED
Owner:
Serial:85551160
Filed:Feb 23, 2012
Classes:5
CYRAMZA
CYRAMZA
Trademark
Word
REGISTERED
Owner:
Serial:85447460
Filed:Oct 14, 2011
Classes:5
Registration:4580501
Registered:Aug 5, 2014
Goods & Services
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cancer
IMCLONE SYSTEMS
IMCLONE SYSTEMS
Trademark
Word
ABANDONED
Owner:
Serial:85230348
Filed:Jan 31, 2011
Classes:5
Goods & Services
"SYSTEMS"
CIRAMZA
CIRAMZA
Trademark
Word
ABANDONED
Owner:
Serial:85202457
Filed:Dec 21, 2010
Classes:5
ENZAVA
ENZAVA
Trademark
Word
ABANDONED
Owner:
Serial:77935753
Filed:Feb 15, 2010
Classes:5
Goods & Services
Class 005: Pharmaceutical preparations in the treatment of cancer; pharmaceutical preparations, namely, monoclonal antibody regulating angiogenesis
LERACERE
LERACERE
Trademark
Word
ABANDONED
Owner:
Serial:77935673
Filed:Feb 15, 2010
Classes:5
Goods & Services
Class 005: Pharmaceutical preparations in the treatment of cancer; pharmaceutical preparations, namely, monoclonal antibody regulating angiogenesis
TOLIENT
TOLIENT
Trademark
Word
ABANDONED
Owner:
Serial:77935682
Filed:Feb 15, 2010
Classes:5
Goods & Services
Class 005: Pharmaceutical preparations in the treatment of cancer; pharmaceutical preparations, namely, monoclonal antibody regulating angiogenesis
VANGIAN
VANGIAN
Trademark
Word
ABANDONED
Owner:
Serial:77935722
Filed:Feb 15, 2010
Classes:5
Goods & Services
Class 005: Pharmaceutical preparations in the treatment of cancer; pharmaceutical preparations, namely, monoclonal antibody regulating angiogenesis
VANJERE
VANJERE
Trademark
Word
ABANDONED
Owner:
Serial:77935723
Filed:Feb 15, 2010
Classes:5
Goods & Services
Class 005: Pharmaceutical preparations in the treatment of cancer; pharmaceutical preparations, namely, monoclonal antibody regulating angiogenesis
VAZARIS
VAZARIS
Trademark
Word
ABANDONED
Owner:
Serial:77935725
Filed:Feb 15, 2010
Classes:5
Goods & Services
Class 005: Pharmaceutical preparations in the treatment of cancer; pharmaceutical preparations, namely, monoclonal antibody regulating angiogenesis
ZERMAVA
ZERMAVA
Trademark
Word
ABANDONED
Owner:
Serial:77935752
Filed:Feb 15, 2010
Classes:5
Goods & Services
Class 005: Pharmaceutical preparations in the treatment of cancer; pharmaceutical preparations, namely, monoclonal antibody regulating angiogenesis
IMCLONE SYSTEMS CORPORATION
ABANDONED
Owner:
Serial:76695201
Filed:Jan 9, 2009
Classes:1, 5, 44
Goods & Services
"SYSTEMS CORPORATION"
STRENGTH IN DATA
STRENGTH IN DATA
Service Mark
Word
ABANDONED
Owner:
Serial:76694253
Filed:Nov 14, 2008
Classes:42
Goods & Services
Class 042: PROVIDING COMPUTERIZED ONLINE MEDICAL AND SCIENTIFIC RESEARCH INFORMATION IN THE FIELD OF ONCOLOGY
76687741
76687741
Trademark
Design
ABANDONED
Owner:
Serial:76687741
Filed:Mar 14, 2008
Classes:1, 5, 42
Goods & Services
PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER; PHARMACEUTICAL PREPARATIONS REGULATING ANGIOGENESIS; PHARMACEUTICAL PREPARATIONS FOR IMMUNOLOGY; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF PSORIASIS; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF OBESITY; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF FIBROSIS; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF INFLAMMATION; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF PRE-CLAMPSIA; VACCINES; DIAGNOSTIC PREPARATIONS FOR RESEARCH USE AND FOR CLINICAL OR MEDICAL LABORATORY USE; PROVIDING COMPUTERIZED ONLINE MEDICAL AND SCIENTIFIC RESEARCH INFORMATION IN THE FIELDS OF IMMUNOLOGY, ONCOLOGY AND ANGIOGENESIS
AKODAR
AKODAR
Trademark
Word
ABANDONED
Owner:
Serial:76680008
Filed:Jul 27, 2007
Classes:5
Goods & Services
PHARMACEUTICAL PREPARATION, NAMELY MONOCLONAL ANTIBODY REGULATING ANGIOGENESIS
CEVANA
CEVANA
Trademark
Word
ABANDONED
Owner:
Serial:76680007
Filed:Jul 27, 2007
Classes:5
Goods & Services
PHARMACEUTICAL PREPARATION, NAMELY MONOCLONAL ANTIBODY REGULATING ANGIOGENESIS
IMACLA
IMACLA
Trademark
Word
ABANDONED
Owner:
Serial:76680006
Filed:Jul 27, 2007
Classes:5
Goods & Services
PHARMACEUTICAL PREPARATION, NAMELY MONOCLONAL ANTIBODY REGULATING ANGIOGENESIS
VANGIO
VANGIO
Trademark
Word
ABANDONED
Owner:
Serial:76680005
Filed:Jul 27, 2007
Classes:5
Goods & Services
PHARMACEUTICAL PREPARATION, NAMELY MONOCLONAL ANTIBODY REGULATING ANGIOGENESIS
ERBITUX CETUXIMAB
ERBITUX CETUXIMAB
Trademark
Combined
REGISTERED
Owner:
Serial:76670452
Filed:Dec 18, 2006
Classes:5
Registration:3333263
Registered:Nov 13, 2007
Goods & Services
PHARMACEUTICAL PREPARATION, NAMELY MONOCLONAL ANTIBODY FOR THE TREATMENT OF CANCER; CETUXIMAB
TARGETED ONCOLOGY
TARGETED ONCOLOGY
Trademark
Combined
CANCELLED
Owner:
Serial:76315638
Filed:Sep 11, 2001
Classes:9, 16, 41, +1
Registration:2859309
Registered:Jul 6, 2004
Goods & Services
[ PROVIDING PUBLIC PRESENTATIONS ON MEDICAL AND SCIENTIFIC TOPICS BY MANNER OF EXHIBITIONS; CONFERENCES; SEMINARS; LECTURES; COLLOQUIA; WORKSHOPS; COURSES ]; [ MULTIMEDIA INFORMATION KITS FEATURING DIGITAL COMPUTER DATA STORAGE MATERIALS, namely, DISKS RELATING TO MEDICAL AND SCIENTIFIC TOPICS IN THE FIELD OF GENETICS, ONCOLOGY AND BIOTECHNOLOGY FOR EDUCATIONAL AND RESEARCH PURPOSES]; [ PRINTED MATTER, namely, LECTURES, PRESS RELEASES AND OTHER INSTRUCTIONAL, EDUCATIONAL AND TEACHING MATERIALS RELATING TO MEDICAL AND SCIENTIFIC TOPICS ]; "TARGETED"; PROVIDING COMPUTERIZED ONLINE INFORMATION ON MEDICAL AND SCIENTIFIC INFORMATION IN THE FIELD OF ONCOLOGY
IMCLONE
IMCLONE
Trademark
Word
REGISTERED
Owner:
Serial:76217093
Filed:Feb 21, 2001
Classes:5, 42
Registration:2923614
Registered:Feb 1, 2005
Goods & Services
PHARMACEUTICAL PREPARATIONS FOR TREATMENT OF CANCER; [ INFORMATION SERVICES RENDERED TO THE PUBLIC BY MEANS OF A GLOBAL COMPUTER INFORMATION NETWORK, PERTAINING TO CANCER, CANCER RESEARCH, TREATMENT OF CANCER, PHARMACEUTICAL PREPARATIONS FOR TREATMENT OF CANCER ]
IMCLONE SYSTEMS
IMCLONE SYSTEMS
Trademark
Word
CANCELLED
Owner:
Serial:76217092
Filed:Feb 21, 2001
Classes:5
Registration:2923613
Registered:Feb 1, 2005
Goods & Services
"SYSTEMS"
IMCLONE SYSTEMS INCORPORATED
CANCELLED
Owner:
Serial:76217095
Filed:Feb 21, 2001
Classes:5, 42
Registration:2923615
Registered:Feb 1, 2005
Goods & Services
"SYSTEMS INCORPORATED"
I
I
Trademark
Combined
CANCELLED
Owner:
Serial:76055927
Filed:May 17, 2000
Classes:5
Registration:2933459
Registered:Mar 15, 2005
Goods & Services
THE REPRESENTATION OF AN ANTIBODY DESIGN OR A DOUBLE HELIX DESIGN
ERBITUX
ERBITUX
Trademark
Word
REGISTERED
Owner:
Serial:76018914
Filed:Apr 4, 2000
Classes:5
Registration:2865372
Registered:Jul 20, 2004
Goods & Services
pharmaceutical preparation, namely, monoclonal antibody for the treatment of cancer

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.